
Company Number
08494015
Next Accounts
Jan 2026
Shareholders
penelope kay wesley
michael david wesley
Group Structure
View All
Industry
Management consultancy activities (other than financial management)
Registered Address
1st floor, meadowside, mountbatten way, congleton, cheshire, CW12 1DY
Website
www.kangahealth.comPomanda estimates the enterprise value of KANGA HEALTH LTD at £3.9m based on a Turnover of £6.8m and 0.57x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of KANGA HEALTH LTD at £0 based on an EBITDA of £-6k and a 4.9x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of KANGA HEALTH LTD at £6.7m based on Net Assets of £2.6m and 2.61x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Kanga Health Ltd is a live company located in congleton, CW12 1DY with a Companies House number of 08494015. It operates in the management consultancy activities other than financial management sector, SIC Code 70229. Founded in April 2013, it's largest shareholder is penelope kay wesley with a 80% stake. Kanga Health Ltd is a established, mid sized company, Pomanda has estimated its turnover at £6.8m with rapid growth in recent years.
Pomanda's financial health check has awarded Kanga Health Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs
7 Strong
2 Regular
2 Weak
Size
annual sales of £6.8m, make it larger than the average company (£445.6k)
- Kanga Health Ltd
£445.6k - Industry AVG
Growth
3 year (CAGR) sales growth of 38%, show it is growing at a faster rate (11.4%)
- Kanga Health Ltd
11.4% - Industry AVG
Production
with a gross margin of 59.8%, this company has a comparable cost of product (59.8%)
- Kanga Health Ltd
59.8% - Industry AVG
Profitability
an operating margin of -0.2% make it less profitable than the average company (8.1%)
- Kanga Health Ltd
8.1% - Industry AVG
Employees
with 20 employees, this is above the industry average (4)
20 - Kanga Health Ltd
4 - Industry AVG
Pay Structure
on an average salary of £51.5k, the company has an equivalent pay structure (£51.5k)
- Kanga Health Ltd
£51.5k - Industry AVG
Efficiency
resulting in sales per employee of £341.9k, this is more efficient (£120.2k)
- Kanga Health Ltd
£120.2k - Industry AVG
Debtor Days
it gets paid by customers after 92 days, this is later than average (62 days)
- Kanga Health Ltd
62 days - Industry AVG
Creditor Days
its suppliers are paid after 89 days, this is slower than average (24 days)
- Kanga Health Ltd
24 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Kanga Health Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 112 weeks, this is more cash available to meet short term requirements (26 weeks)
112 weeks - Kanga Health Ltd
26 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 20.9%, this is a lower level of debt than the average (53.4%)
20.9% - Kanga Health Ltd
53.4% - Industry AVG
Kanga Health Ltd's latest turnover from April 2024 is estimated at £6.8 million and the company has net assets of £2.6 million. According to their latest financial statements, Kanga Health Ltd has 20 employees and maintains cash reserves of £1.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||
Other Income Or Grants | |||||||||||
Cost Of Sales | |||||||||||
Gross Profit | |||||||||||
Admin Expenses | |||||||||||
Operating Profit | |||||||||||
Interest Payable | |||||||||||
Interest Receivable | |||||||||||
Pre-Tax Profit | |||||||||||
Tax | |||||||||||
Profit After Tax | |||||||||||
Dividends Paid | |||||||||||
Retained Profit | |||||||||||
Employee Costs | |||||||||||
Number Of Employees | 20 | 15 | 17 | 14 | 10 | 9 | 7 | 6 | |||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 16,050 | 13,314 | 14,970 | 17,968 | 21,751 | 6,939 | 9,091 | 5,920 | 9,880 | 3,772 | 762 |
Intangible Assets | |||||||||||
Investments & Other | 11,000 | 1,000 | 1,000 | 1,000 | |||||||
Debtors (Due After 1 year) | |||||||||||
Total Fixed Assets | 27,050 | 14,314 | 15,970 | 17,968 | 22,751 | 6,939 | 9,091 | 5,920 | 9,880 | 3,772 | 762 |
Stock & work in progress | |||||||||||
Trade Debtors | 1,740,740 | 1,932,800 | 1,572,517 | 577,733 | 336,153 | 400,343 | 560,444 | 329,529 | 295,351 | 309,786 | 157,403 |
Group Debtors | |||||||||||
Misc Debtors | 5,282 | 8,550 | |||||||||
Cash | 1,462,192 | 1,678,671 | 1,657,349 | 1,968,706 | 1,769,137 | 1,580,081 | 1,391,619 | 985,345 | 351,198 | 175,927 | 66,480 |
misc current assets | 1,000 | ||||||||||
total current assets | 3,202,932 | 3,611,471 | 3,229,866 | 2,547,439 | 2,105,290 | 1,980,424 | 1,952,063 | 1,320,156 | 655,099 | 485,713 | 223,883 |
total assets | 3,229,982 | 3,625,785 | 3,245,836 | 2,565,407 | 2,128,041 | 1,987,363 | 1,961,154 | 1,326,076 | 664,979 | 489,485 | 224,645 |
Bank overdraft | 7 | ||||||||||
Bank loan | |||||||||||
Trade Creditors | 675,094 | 1,123,614 | 1,164,352 | 655,521 | 632,473 | 869,564 | 153,871 | 95,906 | 48,468 | 285,840 | 163,369 |
Group/Directors Accounts | |||||||||||
other short term finances | |||||||||||
hp & lease commitments | |||||||||||
other current liabilities | 682,368 | 683,522 | 165,079 | ||||||||
total current liabilities | 675,094 | 1,123,614 | 1,164,352 | 655,521 | 632,473 | 869,564 | 836,239 | 779,428 | 213,554 | 285,840 | 163,369 |
loans | |||||||||||
hp & lease commitments | |||||||||||
Accruals and Deferred Income | |||||||||||
other liabilities | 7,022 | ||||||||||
provisions | 754 | 152 | |||||||||
total long term liabilities | 7,022 | 754 | 152 | ||||||||
total liabilities | 675,094 | 1,123,614 | 1,164,352 | 662,543 | 632,473 | 869,564 | 836,239 | 779,428 | 213,554 | 286,594 | 163,521 |
net assets | 2,554,888 | 2,502,171 | 2,081,484 | 1,902,864 | 1,495,568 | 1,117,799 | 1,124,915 | 546,648 | 451,425 | 202,891 | 61,124 |
total shareholders funds | 2,554,888 | 2,502,171 | 2,081,484 | 1,902,864 | 1,495,568 | 1,117,799 | 1,124,915 | 546,648 | 451,425 | 202,891 | 61,124 |
Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||
Operating Profit | |||||||||||
Depreciation | 6,129 | 5,509 | 7,215 | 10,524 | 8,120 | 5,262 | 6,332 | 4,976 | 3,615 | 1,257 | 254 |
Amortisation | |||||||||||
Tax | |||||||||||
Stock | |||||||||||
Debtors | -192,060 | 360,283 | 994,784 | 241,580 | -64,190 | -160,101 | 225,633 | 30,910 | -5,885 | 152,383 | 157,403 |
Creditors | -448,520 | -40,738 | 508,831 | 23,048 | -237,091 | 715,693 | 57,965 | 47,438 | -237,372 | 122,471 | 163,369 |
Accruals and Deferred Income | -682,368 | -1,154 | 518,443 | 165,079 | |||||||
Deferred Taxes & Provisions | -754 | 602 | 152 | ||||||||
Cash flow from operations | |||||||||||
Investing Activities | |||||||||||
capital expenditure | |||||||||||
Change in Investments | 10,000 | 1,000 | -1,000 | 1,000 | |||||||
cash flow from investments | |||||||||||
Financing Activities | |||||||||||
Bank loans | |||||||||||
Group/Directors Accounts | |||||||||||
Other Short Term Loans | |||||||||||
Long term loans | |||||||||||
Hire Purchase and Lease Commitments | |||||||||||
other long term liabilities | -7,022 | 7,022 | |||||||||
share issue | |||||||||||
interest | |||||||||||
cash flow from financing | |||||||||||
cash and cash equivalents | |||||||||||
cash | -216,479 | 21,322 | -311,357 | 199,569 | 189,056 | 188,462 | 406,274 | 634,147 | 175,271 | 109,447 | 66,480 |
overdraft | -7 | 7 | |||||||||
change in cash | -216,479 | 21,322 | -311,357 | 199,569 | 189,056 | 188,462 | 406,274 | 634,154 | 175,264 | 109,447 | 66,480 |
Perform a competitor analysis for kanga health ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in CW12 area or any other competitors across 12 key performance metrics.
KANGA HEALTH LTD group structure
Kanga Health Ltd has no subsidiary companies.
Ultimate parent company
KANGA HEALTH LTD
08494015
Kanga Health Ltd currently has 4 directors. The longest serving directors include Ms Penelope Wesley (Apr 2013) and Dr Charlotte Allen (May 2020).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Penelope Wesley | 61 years | Apr 2013 | - | Director | |
Dr Charlotte Allen | United Kingdom | 46 years | May 2020 | - | Director |
Mr Paul Allen | England | 48 years | May 2020 | - | Director |
Mr Michael Wesley | United Kingdom | 68 years | May 2020 | - | Director |
P&L
April 2024turnover
6.8m
-3%
operating profit
-12.2k
0%
gross margin
59.8%
+1.03%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
2.6m
+0.02%
total assets
3.2m
-0.11%
cash
1.5m
-0.13%
net assets
Total assets minus all liabilities
company number
08494015
Type
Private limited with Share Capital
industry
70229 - Management consultancy activities (other than financial management)
incorporation date
April 2013
age
12
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
April 2024
previous names
N/A
accountant
-
auditor
-
address
1st floor, meadowside, mountbatten way, congleton, cheshire, CW12 1DY
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to kanga health ltd.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for KANGA HEALTH LTD. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|